Genetic Safety Study of Chlorpromazine / 신경정신의학
Journal of Korean Neuropsychiatric Association
;
: 629-637, 2000.
Artículo
en Coreano
| WPRIM
| ID: wpr-56033
ABSTRACT
OBJECT The aim of this study is to determine whether exposure to chlorpromazine causes mutagenicity and genetic disorders. METHOD:
Ames (Salmonella typhimurium) test and Rec assay (Bacillus subtilis) were used as indicators for DNA damage. Furthermore, the levels of umu operon expression by measuring the beta-galactosidase activity were monitered with the SOS umu test using S. typhimurium 1535 containing plasmid pSK1002. And the host-mediated assay was used to investigate the muta-genicity of chlorpromazine after the activation with in vivo metabolic systems.RESULTS:
From the results, chlorpromazine did not affect DNA of S. typhimurium and B. subtilis strains and showed no mutagenicity at the all concentrations tested. These phenomena was also similar to that after metabolic activation of chlorpromazine in in vivo system.CONCLUSION:
These results suggested that chlorpromazine did not show the mutagenicity and genotoxicity by four different methods used in this study.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Operón
/
Plásmidos
/
Daño del ADN
/
ADN
/
Biotransformación
/
Clorpromazina
/
Beta-Galactosidasa
Idioma:
Coreano
Revista:
Journal of Korean Neuropsychiatric Association
Año:
2000
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS